Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics (TADCAROC)

Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics (TADCAROC)

The purpose of this study is to examine the content of the treatment being delivered for anxiety disorders for children and adolescents in the regular outpatient clinics in western Norway. The study will also collect data before and after treatment to evaluate the result of the treatment. Furthermore, as part of the study we aim to collect normative data on two questionnaires used to identify anxiety symptoms and the extent to which anxiety interfere with daily functioning. We also aim to develop a quality indicator for anxiety treatment that can be used to monitor treatment in the regular outpatient service, based on the results of the current study.

Study Overview

• Status: Active, not recruiting
• Conditions: Anxiety Disorders
• Intervention / Treatment: Other: Psychosocial treatment

• Study Type: Observational
• Enrollment (Anticipated): 260

Contacts and Locations

Study Locations

• Norway
  • Rogaland
    • Stavanger, Rogaland, Norway, 4011
      • BUPA Helse Stavanger

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 7 years to 17 years (Child)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Children/adolescents from 7-17 years old referred to ordinary outpatient mental health service.

Description

Inclusion Criteria:

• Clinical diagnosis of an anxiety disorder (including PTSD and OCD) based on the diagnostic interview ADIS (ADIS-C/P; Silverman & Albano, 1996).
• The anxiety disorder is the patients primary diagnosis.
• Informed concent is given.

Exclusion Criteria:

• The patient is in need for other primary treatment intervention (e.g., psychosis, suicidality risk)

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Psychosocial treatment; Children and adolescents with anxiety disorders	Other: Psychosocial treatment; Regular psychosocial treatment in clinical outpatient service.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The Anxiety Disorder Interview Schedule for Diagnostic and Statistical Manual (DSM-IV), child and parent versions (ADIS- C/P; Silverman & Albano, 1996).	Diagnostic interview for anxiety disorders and other comorbid disorders. For the 10-year follow-up we anticipate to use another version of the diagnostic interview schedule based on revised diagnostic criteria for anxiety disorders.	The primary outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.

Secondary Outcome Measures

Outcome Measure	Time Frame
Children's Anxiety Life Interference Scale (CALIS; Lyneham et al., 2013)	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).
The Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1999).	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).
Spence Children's Anxiety Scale (SCAS; Spence, 1998)	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).
The Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997)	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks)
Short Mood & Feeling Questionaire (SMFQ; Angold et al., 1995).	This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks)
Clinical Global Impressions (CGI; Guy, 1976).	The outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.

Collaborators and Investigators

• Sponsor: Helse Stavanger HF
• Collaborators: Helse Vest
• Investigators: Principal Investigator: Jon F Bjaastad, D. Psych, Division of Psychiatry, Stavanger University Hospital, N-4068 Stavanger, Norway

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2014
• Primary Completion (Anticipated): December 31, 2028
• Study Completion (Anticipated): December 31, 2029

Study Registration Dates

• First Submitted: August 8, 2014
• First Submitted That Met QC Criteria: August 14, 2014
• First Posted (Estimate): August 18, 2014

Study Record Updates

• Last Update Posted (Actual): May 16, 2023
• Last Update Submitted That Met QC Criteria: May 15, 2023
• Last Verified: November 1, 2022

More Information

Terms related to this study

• Keywords: Adolescent; Anxiety; Outpatient; Children; Effectiveness
• Additional Relevant MeSH Terms: Mental Disorders; Anxiety Disorders
• Other Study ID Numbers: ID416

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO